Keol-C (Oxygen)

Oxygen in Keol-C diffuses across the alveolar membrane into the bloodstream, raising the partial pressure of arterial oxygen. This increased gradient enhances oxygen delivery to tissues, supporting cellular metabolism and correcting low blood‑oxygen levels.

The dose of Keol-C is determined by the prescribing clinician based on the patient’s oxygen saturation, underlying condition, and therapeutic goals. Dosage is individualized and may involve adjusting flow rates or concentration delivered via a cylinder or delivery system.

Safety data for oxygen therapy in pregnancy and lactation are limited. Oxygen is generally considered compatible with use when clinically indicated, but the prescriber should evaluate the risk‑benefit ratio for each individual patient.

To order Keol-C, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Keol-C provides medical‑grade oxygen in a cylinder format, similar to other supplemental oxygen products. Differences may include cylinder size, purity specifications, and regulatory compliance. Clinicians choose based on the clinical setting, required flow rates, and logistical considerations.

Keol-C cylinders should be stored at ambient temperature in a well‑ventilated area, upright, and protected from heat sources and direct sunlight. Ensure cylinders are secured to prevent tipping and follow local regulations for medical gas storage.

Keol-C is administered by inhalation using a regulated delivery system such as a flowmeter, mask, or nasal cannula. The prescriber sets the flow rate and concentration appropriate for the patient’s condition, and the device delivers oxygen directly to the airway.

Serious risks include oxygen toxicity, which can lead to lung injury or seizures at high concentrations, and fire hazards because oxygen supports combustion. Patients with certain lung diseases may also experience CO₂ retention if oxygen is not carefully titrated.

Keol-C should be avoided in patients with known hypersensitivity to oxygen, those with uncontrolled fire‑hazard environments, and individuals with certain pulmonary conditions where high‑concentration oxygen could worsen CO₂ retention, unless closely monitored by a healthcare professional.